BioCardia's CEO Update at Investment Conference in New York

BioCardia CEO Looks Forward to Global Investment Conference

SUNNYVALE, Calif. — BioCardia, Inc. [NASDAQ:BCDA], a pioneer in the development of cellular therapies for cardiovascular and pulmonary conditions, is set to have its President and CEO, Peter Altman, share critical advancements at the upcoming H.C. Wainwright 27th Annual Global Investment Conference.

Conference Highlights

Dr. Altman will be presenting on an exciting journey toward innovative therapeutic solutions at the conference held at the Lotte Palace Hotel in New York City. At 2:00 PM ET on Wednesday, he will outline the company’s progress, specifically focusing on its three clinical programs aimed at addressing ischemic heart disease.

Key Presentations and Topics

During this informative session, Dr. Altman will delve into the ongoing regulatory discussions with the FDA and Japan's PMDA regarding the CardiAMP cell therapy, particularly aimed at treating heart failure, as well as the Helix™ transendocardial delivery catheter.

Moreover, attendees will learn about the exciting new partnership behind the development and commercialization of Heart3D fusion imaging, along with updates on the funding status for BioCardia's CardiALLO allogeneic mesenchymal stem cell program dedicated to heart failure treatments.

Engagement Opportunities

As part of the conference, Dr. Altman will also be available for one-on-one meetings with interested investors. This offers a unique chance to engage directly and gain deeper insights into the company’s trajectory and groundbreaking therapies.

Networking at the Conference

Conference participants are encouraged to schedule meetings through the event's portal, connect with their HCW representatives, or reach out directly to the company for personal discussions via the investor email contact.

Event Timing and Location

The H.C. Wainwright Global Investment Conference is taking place from September 8-10. Here are some pivotal details about Dr. Altman's presentation:

Date: September 10, 2025
Time: 2:00 PM ET
Location: Lotte New York Palace Hotel

About BioCardia's Innovations

BioCardia continues to lead the charge in regenerative medicine, focusing on cellular and cell-derived therapeutics tailored for cardiovascular and pulmonary diseases. Their platforms, including CardiAMP and CardiALLO, reflect the commitment and ingenuity of a company that is rapidly gaining attention within the healthcare sector.

Utilizing advanced technologies like their Helix biotherapeutic delivery system and Morph vascular navigation, BioCardia is paving the way for the next generation of treatments that significantly enhance patient outcomes.

Company Background

Headquartered in Sunnyvale, California, BioCardia is on a mission to transform heart disease treatment through innovative therapies. Their work resonates within the healthcare community as they strive to develop solutions that improve the lives of patients.

Media and Investor Relations Contact

For further inquiries, please contact:
Miranda Peto
Marketing / Investor Relations
Email: mpeto@biocardia.com
Phone: (650) 226-0120

David McClung
Chief Financial Officer
Email: investors@biocardia.com
Phone: (650) 226-0120

Frequently Asked Questions

What is the main topic of Dr. Altman's presentation?

Dr. Altman will discuss BioCardia's three clinical cell therapy programs and recent regulatory activities.

Where will the conference be held?

The conference will take place at the Lotte Palace Hotel in New York City.

How can attendees engage with Dr. Altman?

Attendees can schedule one-on-one meetings with Dr. Altman through the event portal or directly via the investor contact email.

What are BioCardia's main therapeutic focuses?

BioCardia is focused on developing therapeutics for cardiovascular and pulmonary diseases.

How can I get more information about BioCardia?

For more details, visit the company’s official website at www.biocardia.com.

About The Author

Dominic Sanders here, a writer and financial specialist committed to helping my readers understand the world of finance. Having a strong financial background and a lot of experience, I concentrate on using my blog posts and articles to translate difficult financial subjects into understandable, doable advice. My goal in writing is to arm you with the information and skills need to make wise financial choices.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors seeking new perspectives to seasoned investors. My mission is to make money understandable and approachable so you may confidently take charge of your financial future. I appreciate you walking this road with me to success and financial literacy.

Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.